Skip to main content

Antibiotics

Exhibiting 64 entries found in the GMN corpus.

YearTitle & TagsAuthor(s)
1946 CEPenicillin: Its practical application. Edited by Sir Alexander Fleming.
1947 CE“Aerosporin”, an antibiotic produced by Bacillus aerosporus Greer.
1952 CE“Ilotycin”, a new antibiotic.
1955 CE​–1956 CEAmphotericins A and B, antifungal antibiotics produced by a streptomycete.
GOLD, W
GOLD, W
& et al.
1949 CEAn antiphage agent isolated from Aspergillus sp.
1940 CEAn enzyme from bacteria able to destroy penicillin.
1889 CEAntibiose et symbiose.
1966 CEAntibiotic susceptibility testing by a standardized single disk method.
1949 CEAntibiotics: A survey of penicillin, streptomycin, and other antimicrobial substances from fungi, actinomycetes, bacteria, and plants. 2 vols.
1948 CEAureomycin; a product of the continuing search for new antibiotics.
1945 CEBacitracin: a new antibiotic produced by a member of the B, subtilis group.
1939 CEBactericidal effect of an extract of a soil bacillus on gram-positive cocci.
1889 CEBakteriolytische Enzyme als Ursache der erworbenen Immunität und die Heilung von Infectionskrankheiten durch dieselben.
1955 CECarcinolytic action of antibiotics: puromycin and actinomycin.
1955 CECephalosporin C, a new antibiotic containing sulpher and d-x aminoadipic acid.
1877 CECharbon et septicémie.
1947 CEChloromycetin, a new antibiotic from a soil actinomycete.
1947 CEChloromycetin, an antibiotic with chemotherapeutic activity in experimental rickettsial and viral infections.
1951 CEFungicidin, an antibiotic produced by a soil actinomycete.
1941 CEFurther observations on penicillin.
1963 CEGentamicin, a new antibiotic complex from Micromonospora.
1925 CEIntravenous use of dyes.
1951 CEIsolation of antibiotics from a species of Cephalosporium. Cephalosporins P1, P2, P3, P4, and P5.
1928 CELes associations microbiennes: Leurs applications thérapeutiques.
2005 CEMacrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: A double blind randomized placebo-controlled trial.
1944 CEMicro-methods of estimating penicillin blood serum and other bodily fluids.
1963 CEMiracle drugs: A history of antibiotics.
1956 CEMitomycin, a new antibiotic from streptomyces.
1949 CENeomycin, a new antibiotic active against streptomycin-resistant bacteria, including tuberculosis organisms.
1922 CEOn a remarkable bacteriolytic element found in secretions and tissues.
1929 CEOn the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae.
1932 CEOn the specific antibacterial properties of penicillin and potassium tellurite. Incorporating a method of demonstrating some bacterial antagonisms.
1948 CEOrally administered penicillin in patients with rheumatic fever.
1943 CEPenicillamine, a characteristic degradation product of penicillin.
1940 CEPenicillin as a chemotherapeutic agent.
1944 CEPenicillin content of blood serum after various doses of penicillin by various routes.
1948 CEPenicillin in subacute bacterial endocarditis. Report to the Medical Research Council on 269 patients treated in 14 centres appointed by the Penicillin Clinical Trials Committee.
1944 CEPenicillin in the treatment of meningitis.
1943 CEPenicillin treatment of early syphilis. A preliminary report.
1947 CEPolymyxin: a new chemotherapeutic agent.
1947 CEProcaine penicillin G (duracillin); a new salt of penicillin which prolongs the action of penicillin.
1957 CEProduction and isolation of a new antibiotic, kanamycin.
UMEZAWA, Hamao & et al.
1954 CEPurification and some properties of cephalosporin N, a new penicillin.
1942 CEPurification of penicillin.
1952 CEReplica plating and indirect selection of bacterial mutants.
1896 CERicerche batteriologische e chimiche sulle alterazioni del mais; contributo all’etiologia della pellagra.
1948 CERicerche su di un nuovo antibiotico.
1902 CESnake venom in relation to haemolysis, bacteriolysis, and toxicity.
1945 CEStreptomycin in treatment of clinical tuberculosis: a preliminary report.
1944 CEStreptomycin, a substance exhibiting antibiotic activity against Grampositive and Gram-negative bacteria.